Press Releases

ToxExpo keeps members and attendees up-to-date on the latest news with Press Release postings.
Exhibitors receive one press release as part of their booth profile, additional may be purchased.

• MatTek Acquired by CELLINK Life Sciences
  Submitted on: Mar 15, 2021, by MatTek Life Sciences (#2027)

  MatTek Corporation has entered into an agreement to be acquired by CELLINK, a world-leading bioconvergence company Ashland, MA – MatTek Corporation, a Boston-area life sciences company specializing in lab-engineered human tissue production, announced today that it has agreed to be acquired by CELLINK, a leader in bioprinting,... Learn More

• Toxys launches ToxProfiler, a novel in vitro assay for mechanism-based cytotoxicity screening
  Submitted on: Mar 10, 2021, by Toxys (#2421)

  Leiden, The Netherlands, 28 January 2021   Toxys has licensed and launched the ToxProfiler assay based on the SafeDesign technology for animal-free chemical safety testing developed by Leiden University and Leiden University Medical Center. ToxProfiler allows for rapid toxicity hazard identification of novel and existing drugs, chemicals, and... Learn More

• Looking for an experienced CRO and also for advancing your EOGRTS timelines?
  Submitted on: Mar 08, 2021, by JRF GLOBAL (#2113)

  JRF Global is an experienced CRO performing DART studies for the last 15 years including Embryo-fetal toxicity, Reproduction and development toxicity studies, Fertility studies, and Multi-Generation studies. In the last five years, JRF has conducted around half a dozen EOGRTS studies that have been well-received by the regulators.  JRF can... Learn More

• Superspreaders, Exhaled Breath and Viral Infectivity
  Submitted on: Mar 03, 2021, by CH Technologies (USA), Inc. (#1841)

  Watch out for the poster presentation by Dr. Rudolph Jaeger, PhD, DABT, ERT (UK) on Human Exhaled Aerosol Particle Monitoring as an Index of Viral Infectivity at the SOT Annual Meeting & ToxExpo Virtual Event on March 24th, 2021 from 11:15 AM - 1 PM (POS-666 COVID-19 Issues). ... Learn More

• NIH Awards Grants to NDRI to Support Autism Research
  Submitted on: Feb 25, 2021, by National Disease Research Interchange (#N-12)

  PHILADELPHIA, PA., April 7, 2020— The National Disease Research Interchange (NDRI) has been awarded a research subcontract of $275,429 to support the National Institutes of Mental Health (NIMH) and the Office of Director aimed at furthering the research of the causes and behavioral associations with individuals... Learn More

• Alfa Wassermann Diagnostic Technologies Introduces COVID-19 Reagent Panel
  Submitted on: Feb 23, 2021, by Alfa Wassermann, Inc. (#1850)

  For Follow-Up Monitoring of COVID-19 Patients in the Physician Office Laboratory WEST CALDWELL, NJ – May 19, 2020 – Alfa Wassermann Diagnostic Technologies, LLC (AWDT) announced today the introduction of a COVID-19 Reagent Panel for follow-up care of vulnerable COVID-19 patients with underlying health conditions. Monitoring patients... Learn More

• LifeNet Health launches newly expanded LifeSciences division with innovative solutions for researchers
  Submitted on: Feb 19, 2021, by LifeNet Health LifeSciences (#1322)

  New LifeSciences division accelerates preclinical discovery and compound evaluation in biotechnology, pharmaceutical and agrochemical companies LifeNet Health LifeSciences’ vertically integrated supply chain provides researchers with unparalleled access to a wide array of human biospecimens as well as high-quality primary cells from both healthy and diseased... Learn More

• Evotec Starts Clinical Development of Chikungunya Antibody together with NIAID and Leading Academic Research Organisation
  Submitted on: Feb 17, 2021, by Evotec, Inc. (#2040)

  Hamburg, Germany, 28 January 2021:  Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that EVT894, a monoclonal antibody to treat and potentially prevent chikungunya virus infections, has entered clinical development.  The Phase I, randomised, double-blind, single centre, single dose escalation study to evaluate... Learn More

• Welcome to Chemon!
  Submitted on: Feb 16, 2021, by Chemon Inc. (#2130)

  Welcome to Chemon! Thank you for visiting Chemon Inc’s nonclinical contract research organization (CRO) website. Chemon was launched as the first private nonclinical testing company in the Republic of Korea at the dawn of the 21st century. Currently we are not only serving... Learn More

• Certara Releases Simcyp™ PBPK Simulator Version 20, Including Newly Expanded Biologics Software
  Submitted on: Feb 05, 2021, by Certara (#1946)

  Published: Jan. 27, 2021 at 8:00 a.m. ET  Certara, Inc., the global leader in biosimulation, today announced the release of version 20 of its Simcyp™ Physiologically-based Pharmacokinetic (PBPK) Simulator platform. Learn More

• Scientists Advancing Public Health Research Honored with 2021 Society of Toxicology Awards
  Submitted on: Jan 06, 2021, by SOT Pavilion (#1420)

  Reston, Va.; December 17, 2020—The Society is pleased to announce and recognize the 2021 SOT Award recipients for their many accomplishments and their commitment to the field of toxicology. The 2021 awardees represent outstanding researchers in academia, industry, and government across the globe and career stages. The work of these... Learn More